Follow
Paraskevi Kirgou
Paraskevi Kirgou
Other namesParaskevi Kyrgou
Biologist, PhD, MSc
Verified email at uth.gr
Title
Cited by
Cited by
Year
Target analysis of volatile organic compounds in exhaled breath for lung cancer discrimination from other pulmonary diseases and healthy persons
M Koureas, P Kirgou, G Amoutzias, C Hadjichristodoulou, ...
Metabolites 10 (8), 317, 2020
802020
Increased monocyte count and red cell distribution width as prognostic biomarkers in patients with Idiopathic Pulmonary Fibrosis
T Karampitsakos, S Torrisi, K Antoniou, E Manali, I Korbila, ...
Respiratory research 22 (1), 140, 2021
492021
Repeated antigen-based rapid diagnostic testing for estimating the coronavirus disease 2019 prevalence from the perspective of the workers’ vulnerability before and during the …
OS Kotsiou, I Pantazopoulos, D Papagiannis, EC Fradelos, ...
International Journal of Environmental Research and Public Health 18 (4), 1638, 2021
192021
Early COVID-19 lockdown in Greece and idiopathic pulmonary fibrosis: a beneficial “impact” beyond any expectation
SA Papiris, D Bouros, K Markopoulou, L Kolilekas, AI Papaioannou, ...
European Respiratory Journal 57 (3), 2021
132021
Pathophysiological aspects of aging in venous thromboembolism: an update
D Akrivou, G Perlepe, P Kirgou, KI Gourgoulianis, F Malli
Medicina 58 (8), 1078, 2022
112022
Mental health and quality of life in pulmonary embolism: a literature review
N Gkena, P Kirgou, KI Gourgoulianis, F Malli
Advances in Respiratory Medicine 91 (2), 174-184, 2023
52023
Serum Levels of Urokinase Plasminogen Activator Receptor (suPAR) Discriminate Moderate Uncontrolled from Severe Asthma
OS Kotsiou, I Pantazopoulos, G Mavrovounis, K Marsitopoulos, ...
Journal of Personalized Medicine 12 (11), 1776, 2022
22022
Changes in Smoking Habits in Greece During the Lockdown Measures Due to COVID-19
IC Lampropoulos, P Kirgou, DG Raptis, E Rouka, O Kotsiou, ...
Worldwide Congress on “Genetics, Geriatrics and Neurodegenerative Diseases …, 2022
12022
Clinical relevance of circulating autoantibodies in idiopathic pulmonary fibrosis; A NAt hard to break
P Kirgou, SI Sinis, IE Dimeas, IC Papanikolaou, K Tatsis, A Gogali, ...
Frontiers in Medicine 9, 964722, 2022
12022
Reduced immunogenicity of the mRNA vaccine BNT162b2 in patients with idiopathic pulmonary fibrosis
T Karampitsakos, O Papaioannou, I Dimeas, P Tsiri, V Sotiropoulou, ...
ERJ open research 8 (2), 2022
12022
Cost-IPFfectiveness of antifibrotic treatment: real-life data from a Greek University Hospital
I Dimeas, S Sinis, P Kirgou, L Ioannis, F Malli, K Gourgoulianis, Z Daniil
European Respiratory Journal 56 (suppl 64), 2020
12020
D-ROMs and PAT Tests Reveal a High Level of Oxidative Stress in Patients with Severe Well-Controlled Asthma, and D-ROMs Are Positively Correlated with R20 Values That Indicate …
OS Kotsiou, K Tourlakopoulos, L Kontopoulou, G Mavrovounis, ...
Journal of Personalized Medicine 13 (6), 943, 2023
2023
Investigation of the Level of Burnout in Health Care Professionals in COVID-19 Pandemic Conditions
A Valavani, E Garavela, IV Papathanasiou, K Tsaras, EC Fradelos, ...
Worldwide Congress on “Genetics, Geriatrics and Neurodegenerative Diseases …, 2022
2022
The system can't perform the operation now. Try again later.
Articles 1–13